NEW YORK (360Dx) – The US Food and Drug Administration today issued a final guidance modifying its policy for categorizing investigational device exemption (IDE) devices used in clinical studies.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.